Development of the sporadic inclusion body myositis physical functioning assessment
Author:
Affiliation:
1. RTI Health Solutions; Research Triangle Park, 200 Park Offices Drive; North Carolina 27709 USA
2. Center for Gene Therapy, Nationwide Children's Hospital; Columbus Ohio USA
3. Novartis Pharmaceuticals; Basel Switzerland
Funder
Novartis Pharmaceuticals
Publisher
Wiley
Subject
Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology
Reference11 articles.
1. US FDA patient-reported outcome guidance: great expectations and unintended consequences;Fehnel;Expert Rev Pharmacoecon Outcomes Res,2013
2. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims;United States Food and Drug Administration;Fed Reg,2009
3. Bradypedia: is gait speed ready for clinical use?;Studenski;J Nutr Health Aging,2009
4. Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM |workshop, London, 13 June 2008;Hilton-Jones;Neuromuscul Disord,2010
5. A purposeful approach to the constant comparative method in the analysis of qualitative interviews;Boeije;Quality Quantity,2002
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany;Orphanet Journal of Rare Diseases;2023-10-25
2. Inclusion body myositis—health-related quality of life and care situation during phases of the “patience journey” in Germany: results from a qualitative study;Health and Quality of Life Outcomes;2023-10-10
3. Patient-Reported Health-Related Quality of Life, Anxiety and Depression in Patients with Inclusion Body Myositis: A Register-Based Cross-Sectional Study in Germany;Journal of Clinical Medicine;2023-07-31
4. Longitudinal Changes in MRI Muscle Morphometry and Composition in People With Inclusion Body Myositis;Neurology;2022-06-03
5. Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis;Neurology;2021-02-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3